Bikash Adhikari

6PUBLICATIONS
43CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsMolecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 18, 2026
Minute-scale control of ubiquitin-mediated degradation reveals dynamics of bacterial secreted effector-functions.

|May 13, 2026
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

|Feb 06, 2026
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.

JuanFei Peng, JiaJin Yang, Georgia Antonopoulou

|Apr 17, 2025
Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networks.

Kristina Wagner, Jan Keiten-Schmitz, Bikash Adhikari

|May 13, 2021
Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders.

Anja Dölle, Bikash Adhikari, Andreas Krämer

|Sep 29, 2020
PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.

Bikash Adhikari, Jelena Bozilovic, Mathias Diebold

Pageof 1

Frequent Collaborators

5 joint publications

Elmar Wolf

3 joint publications

Stefan Knapp

2 joint publications

Bernhard Kuster

2 joint publications

Markus Vogt